Vicore builds case for C21 drug in hospitalised COVID-19 patientsTwo weeks ago, Vicore reported mid-stage data showing that its lead drug C21 could boost the benefit of Share XVicore builds case for C21 drug in hospitalised COVID-19 patientshttps://pharmaphorum.com/news/vicore-builds-case-for-c21-drug-in-hospitalised-covid-19-patients/
